Epitalon vs NAD+
Synthetic tetrapeptide telomerase activator vs essential coenzyme for cellular energy — two distinct approaches to longevity and cellular ageing research.
Last updated: 2026-03-08
Quick Comparison Table
| Category | Epitalon | NAD+ |
|---|---|---|
| Molecule Type | Synthetic tetrapeptide (Ala-Glu-Asp-Gly) | Coenzyme (Nicotinamide Adenine Dinucleotide) |
| Primary Mechanism | Telomerase activation → telomere elongation | NAD+/NADH redox cycling → sirtuin activation → DNA repair |
| Key Target | Telomere length / cell replicative capacity | Cellular energy metabolism / epigenetic regulation |
| Administration | SC injection (10-day cycles) | Oral (NMN/NR precursors), IV, SC |
| Evidence Level | Preclinical + limited Russian clinical data | Extensive preclinical + emerging clinical trials |
| Availability | Research peptide (unregulated) | Widely available as supplement (NMN/NR) |
| Longevity Pathway | Telomere biology | NAD+/sirtuin/PARP pathway |
| Pineal Connection | Pineal peptide (stimulates melatonin) | Circadian rhythm regulation via SIRT1 |
Mechanism of Action
Epitalon
Epitalon Mechanism:
Epitalon (Epithalon, Epithalone) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) based on the natural pineal peptide Epithalamin, developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology.
Key actions: 1. **Telomerase activation** — Induces hTERT (telomerase reverse transcriptase) expression, enabling telomere elongation 2. **Pineal gland stimulation** — Increases melatonin production and restores circadian rhythmicity 3. **Antioxidant gene expression** — Upregulates SOD and catalase 4. **Chromatin remodelling** — Promotes euchromatin state in senescent cells
The telomere-centric mechanism positions Epitalon as addressing a fundamental cause of cellular ageing — the progressive shortening of telomeres with each cell division (the Hayflick limit).
NAD+
NAD+ Mechanism:
NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme present in all living cells, essential for hundreds of metabolic reactions.
Key actions: 1. **Sirtuin activation** — NAD+ is the essential cofactor for SIRT1-7, which regulate DNA repair, inflammation, metabolism, and circadian rhythms 2. **PARP activation** — NAD+ fuels poly(ADP-ribose) polymerases for DNA damage repair 3. **Redox cycling** — NAD+/NADH ratio drives mitochondrial electron transport and ATP production 4. **CD38/SARM1** — NAD+ consuming enzymes increase with age, driving the age-related NAD+ decline 5. **Epigenetic regulation** — Sirtuins modulate histone deacetylation and gene silencing
NAD+ levels decline 40-60% between ages 20-60, and this decline is implicated in metabolic dysfunction, neurodegeneration, and immune senescence. Supplementation with precursors (NMN, NR) aims to restore youthful NAD+ levels.
Clinical Trial Evidence
Epitalon Clinical Studies
Participants: 266
Duration: 6 years
Epithalamin (Epitalon precursor) reduced cardiovascular mortality by 50% in elderly cohort over 6 years. Improved melatonin and immune markers.
Statistically significant
Participants: 0
Duration: In vitro
Epitalon reactivated telomerase in human fetal fibroblasts, extending replicative lifespan beyond Hayflick limit.
Statistically significant
Participants: 30
Duration: 3 months
Epitalon restored nocturnal melatonin peak in elderly subjects with age-related melatonin decline.
Statistically significant
Participants: 0
Duration: Lifespan study
Epitalon extended mean lifespan of Drosophila by 11-16%. Largest effect in oldest cohorts.
Statistically significant
Participants: 0
Duration: 6 months
Epitalon preserved retinal cell function in rats with hereditary retinal degeneration. Maintained electroretinogram responses.
Statistically significant
NAD+ Clinical Studies
Participants: 25
Duration: 10 weeks
250mg/day NMN improved muscle insulin sensitivity in prediabetic postmenopausal women. NAD+ metabolites increased.
Statistically significant
Participants: 120
Duration: 6 weeks
NR (1000mg/day) increased NAD+ levels by 60% in middle-aged/older adults. Well-tolerated. No significant functional endpoints.
Statistically significant
Participants: 3000
Duration: Cross-sectional
NAD+ levels decline 40-60% between ages 20-60. Low NAD+ correlates with cardiometabolic risk factors and frailty.
Statistically significant
Participants: 48
Duration: 6 weeks
NMN (600mg/day) improved aerobic capacity (VO2max) and power output during exercise training in healthy adults.
Statistically significant
Participants: 20
Duration: 6 sessions
IV NAD+ (750mg) improved self-reported energy, mental clarity, and sleep quality. Significant infusion-site discomfort noted.
Not statistically significant
Benefits Comparison
Epitalon Unique Benefits
- Direct telomerase activation
- Melatonin restoration in elderly
- Potential replicative lifespan extension
- Antioxidant gene upregulation
- Pineal gland rejuvenation
Shared Benefits
- Longevity/anti-ageing research application
- Decline with age (replacement rationale)
- Cellular rejuvenation mechanism
- Potential synergy with healthy lifestyle
NAD+ Unique Benefits
- Essential for 500+ metabolic reactions
- Sirtuin activation (master regulators of ageing)
- Widely available as supplement (NMN/NR)
- Multiple ongoing human clinical trials
- Improved insulin sensitivity and exercise capacity
Research & Evidence
Epitalon Research
Epitalon research is primarily from the Khavinson laboratory in Russia. While results are intriguing (telomerase activation, lifespan extension in model organisms), the studies have limited Western peer review and small sample sizes. No international Phase II/III clinical trials have been conducted.
NAD+ Research
NAD+ biology is one of the most active areas in ageing research globally. NMN and NR have been studied in multiple human clinical trials, and the basic science of NAD+/sirtuin biology has been validated by numerous independent laboratories worldwide. David Sinclair (Harvard) and Shin-ichiro Imai (Washington University) have led pioneering research.
Head-to-Head Analysis
Direct Comparison:
No head-to-head study exists.
Different Ageing Theories: Epitalon targets telomere biology — the "replicative clock" of cells. NAD+ targets metabolic and epigenetic ageing — the "functional clock" of cellular health. These represent distinct but potentially complementary hallmarks of ageing.
Evidence Quality: NAD+ has a much larger and more rigorous research base, including multiple ongoing human clinical trials with NMN and NR precursors. Epitalon's evidence comes primarily from Russian research groups, with limited peer review in Western journals.
Accessibility: NAD+ precursors (NMN, NR) are widely available as supplements. Epitalon is a research peptide requiring injection and is not available as a consumer supplement.
Protocol Comparison
Epitalon Protocol
Epitalon Theoretical Protocols (Research-Based):
Common Protocol: 5-10mg SC injection daily for 10 days. Repeat cycle every 4-6 months.
Alternative: 10mg every other day for 20 days (total 100mg per cycle).
Routes: SC injection. IV used in some Russian clinical settings.
⚠️ Disclaimer: Not approved for clinical use. Research peptide only.
NAD+ Protocol
NAD+ / NMN / NR Protocols:
NMN (Oral): 250-1000mg daily. Most clinical trials use 250-600mg.
NR (Oral — Niagen): 300-1000mg daily. 500mg twice daily used in CHROME trial.
IV NAD+ (Clinical Settings): 250-750mg IV infusion over 2-4 hours. Used in integrative medicine clinics.
Note: NMN and NR are NAD+ precursors — they are converted to NAD+ in the body. Direct NAD+ supplementation requires IV administration due to poor oral bioavailability.
Safety Profiles
Epitalon Safety
Epitalon Safety:
No serious adverse events reported in published studies. Well-tolerated in the Russian elderly cohort study over 6 years. As a short tetrapeptide, immunogenicity risk is very low.
Limited safety database by Western pharmaceutical standards. Long-term safety of chronic telomerase activation is a theoretical concern (though no evidence of increased cancer risk has been reported).
NAD+ Safety
NAD+ / NMN / NR Safety:
NMN and NR are well-tolerated in clinical trials at doses up to 1200mg/day. Side effects are minimal — mild GI discomfort at higher doses.
IV NAD+ causes infusion-site discomfort and sometimes nausea, chest tightness, or cramping during infusion. These resolve after infusion completion.
Theoretical concerns: Long-term high-dose NAD+ supplementation effects on cancer risk (NAD+ supports both healthy and cancerous cell metabolism) are being actively studied.
The Verdict
NAD+ has a stronger and more internationally validated evidence base, broader availability (oral supplements), and more clinical trials supporting its role in ageing. Epitalon targets a different ageing hallmark (telomere biology) with intriguing but less rigorously validated evidence. For practical longevity supplementation, NAD+ precursors (NMN/NR) are more accessible and evidence-supported. For researchers interested in telomere biology, Epitalon remains a unique tool. They address different mechanisms and could theoretically be complementary.
Frequently Asked Questions
Conclusion
Epitalon and NAD+ represent two distinct pillars of longevity research — telomere biology and cellular energetics, respectively. NAD+ supplementation via NMN/NR precursors has the stronger international evidence base, greater accessibility, and broader mechanistic relevance (500+ enzymatic reactions). Epitalon's telomerase activation offers a unique, targeted approach to replicative ageing but with a smaller, less internationally validated evidence base. Both address fundamental hallmarks of ageing and may represent complementary strategies in a multi-targeted longevity approach.
Medical Disclaimer
The information provided in this comparison is for educational and research purposes only. Neither Epitalon nor NAD+ is approved for human therapeutic use by the MHRA, EMA, or FDA. This content does not constitute medical advice. Always consult a qualified healthcare professional before considering any peptide or supplement.